BINGHAM KATE

BCYC

BINGHAM KATE serves as Director at Bicycle Therapeutics plc (BCYC). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$1.53M

Net Position

Net Seller

$1.53M

Companies Traded

BCYC

Active Period

Jul 2021

1 total trades

Most Recent

Sell BCYC

Jul 13, 2021 · $1.53M

BINGHAM KATE's Insider Trading at Bicycle Therapeutics plc (BCYC)

Buys

0 · $0.00

Sells

1 · $1.53M

Total Shares Bought

Total Shares Sold

44,895

BCYC Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 13, 2021	Sell	44,895	$34.00	$1.53M	0

Related Insiders

Michael Skynner

CHIEF TECHNOLOGY OFFICER

BCYCSell · Jan 2, 2026

Kevin Lee

CHIEF EXECUTIVE OFFICER

BCYCSell · Jan 2, 2026

Alistair Milnes

CHIEF OPERATING OFFICER

BCYCSell · Jan 2, 2026

Michael Charles Ferguson Hannay

CHIEF PROD & SUPPLY CHAIN OFF

BCYCSell · Jan 2, 2026

Alethia Young

Chief Financial Officer

BCYCSell · Jan 2, 2026

Travis Alvin Thompson

CHIEF ACCOUNTING OFFICER

BCYCSell · Jan 2, 2026

Robert Charles Swanton

Director

BCYCSell · Oct 2, 2025

Explore More Insider Trading Data

BCYC Insider Trading Activity

View all insider trades at Bicycle Therapeutics plc

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity